ZOUNDTH Trademark
Trademark Overview
On Thursday, April 20, 2023, a trademark application was filed for ZOUNDTH with the United States Patent and Trademark Office. The USPTO has given the ZOUNDTH trademark a serial number of 97898061. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, September 17, 2025. This trademark is owned by Eli Lilly and Company. The ZOUNDTH trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative co...
General Information
| Serial Number | 97898061 |
| Word Mark | ZOUNDTH |
| Filing Date | Thursday, April 20, 2023 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Wednesday, September 17, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 27, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 28, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
Trademark Events
| Event Date | Event Description |
| Thursday, January 18, 2024 | ASSIGNED TO EXAMINER |
| Monday, January 22, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, April 24, 2023 | NEW APPLICATION ENTERED |
| Friday, April 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 7, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, February 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, March 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, September 25, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 27, 2024 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 25, 2024 | SOU EXTENSION 1 FILED |
| Wednesday, September 25, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, March 14, 2025 | SOU TEAS EXTENSION RECEIVED |
| Friday, March 14, 2025 | SOU EXTENSION 2 FILED |
| Wednesday, September 25, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, March 14, 2025 | SOU EXTENSION 2 GRANTED |
| Saturday, March 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 17, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 17, 2025 | SOU EXTENSION 3 FILED |
| Wednesday, September 17, 2025 | SOU EXTENSION 3 GRANTED |
| Thursday, September 18, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
